Ningbo David Medical Device Co., Ltd. / Fundamentals
Income statement
- Net revenue
€59.39M - Cost of goods sold
€26.60M - Gross profit
€32.79M - SG&A expenses
€15.53M - R&D expenses
€7.05M - EBITDA
€6.71M - D&A
€878.85K - EBIT
€5.09M - Interest expenses
€94.35K - EBT
€5.73M - Tax expenses
€374.45K - Net income
€5.05M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€1.49M - Changes in working capital
€0.00 - Operating cash flow
€1.63M - Capex
€15.35M - Other investing cash flow
-€7.26M - Net investing cash flow
-€21.50M - Total cash dividends paid
-€4.14M - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
-€2.74M - Net financing cash flow
-€6.88M - Foreign exchange effects
€35.35K - Net change in cash
-€19.33M - Cash at end of period
€34.27M - Free cash flow
€16.97M
Balance sheet
- Cash and cash equivalents
€35.98M - Cash and short-term investments
€75.93M - Total receivables
€5.11M - Inventory
€23.62M - Other current assets
€2.19M - Total current assets
€106.85M - Property, plant & equipment
€41.00M - Goodwill
€0.00 - Intangible assets
€5.61M - Long-term investments
-€32.84M - Other non-current assets
€46.73M - Total non-current assets
€60.87M - Total assets
€167.72M - Accounts payable
€14.83M - Short-term debt
€0.00 - Other current liabilities
€7.15M - Total current liabilities
€22.27M - Long-term debt
€734.85K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€1.20M - Total liabilities
€23.47M - Common stock
€34.86M - Retained earnings
€77.14M - Other equity
€0.00 - Total equity
€144.25M - Total liabilities and shareholders' equity
€167.72M
Company information
- Market capitalization
€435.19M - Employees
916 - Enterprise Value
€3.42B
Company ratios
- Gross margin
-
55.2% Worse than peer group: 63.6% - EBITDA margin
-
11.3% Worse than peer group: 28.8% - EBIT margin
-
8.6% Worse than peer group: 23.4% - EBT margin
-
9.7% Worse than peer group: 24.9% - Net margin
-
8.5% Worse than peer group: 20.8% - ROE
-
3.5% Worse than peer group: 8.9% - ROA
-
3.0% Even with peer group: 7.0% - Asset turnover
-
35.4% Even with peer group: 34.7% - FCF margin
-
-23.1% Much worse than peer group: 2.4% - FCF yield
-3.2% - Efficiency ratio
88.7% - Net sales per employee
-
€64.83K - Net income per employee
-
€5.51K